Current situation and thinking of perioperative treatment of esophageal cancer
10.3781/j.issn.1000-7431.2024.2306-0322
- VernacularTitle:食管癌围手术期治疗现状和思考
- Author:
Xiangyuan LI
1
;
Rong XIAO
;
Meiling ZHU
Author Information
1. 上海交通大学医学院附属新华医院肿瘤科,上海 200092
- Keywords:
Esophageal cancer;
Perioperative period;
Immunotherapy;
Neoadjuvant chemoradiotherapy;
Precise treatment
- From:
Tumor
2024;44(1):54-61
- CountryChina
- Language:Chinese
-
Abstract:
For many years,the perioperative treatment of esophageal cancer in China has been based on chemotherapy or chemoradiotherapy.However,in the recent years,with the emergence of immunotherapy represented by immune checkpoint inhibitors,multidisciplinary comprehensive treatment,precise treatment under the guidance of molecular pathology,and guided selection of different therapies under the guidance of different tumor load phenotypes(T/N load relative relationship),the traditional model of perioperative treatment of esophageal cancer is faced with challenges.Nonetheless,it has also provided new opportunities to re-examine the current perioperative treatment model of esophageal cancer,which will also help to promote the optimization of perioperative treatment strategies for esophageal cancer.Therefore,it is necessary to fully understand and further think about the current situation of perioperative treatment of esophageal cancer.
